- Tytuł:
- Clinical and Economic Benefits of Lenzilumab Plus Standard of Care Compared with Standard of Care Alone for the Treatment of Hospitalized Patients with Coronavirus Disease 19 (COVID-19) from the Perspective of National Health Service England
- Autorzy:
- Temat:
-
economic analysis
crp
gm-csf
ventilator-free survival
survival without ventilation
invasive mechanical ventilation
Medicine (General)
R5-920
Therapeutics. Pharmacology
RM1-950 - Źródło:
- ClinicoEconomics and Outcomes Research, Vol Volume 14, Pp 231-247 (2022)
- Opis pliku:
- electronic resource
- Relacje:
- https://www.dovepress.com/clinical-and-economic-benefits-of-lenzilumab-plus-standard-of-care-com-peer-reviewed-fulltext-article-CEOR; https://doaj.org/toc/1178-6981
- Dostęp URL:
- https://doaj.org/article/700c660904a64c54b2b938ddcc8e0199  Link otwiera się w nowym oknie
Czasopismo naukowe